Adequate Hydration Therapy Combined With Intravenous Infusion of Isosorbide Dinitrate Prevention for CIN

NCT02718521 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Cardio-Renal Syndrome

Interventions

PROCEDURE: Hydration Combined With Intravenous Infusion of Isosorbide Dinitrate
DRUG: Visipaque
DRUG: 0.9% sodium chloride ﬂuid administration
DRUG: isosorbide dinitrate

Sponsor

Chinese PLA General Hospital